NIHR Maudsley BRC Blog

Our latest news and events

Experts with lived experience address mental health stigma

The community engagement event, “Voices of Experience: Breaking Mental Health Stigma”, was hosted at Peckham Levels in South East London in May 2025 as part of Mental Health Awareness Week.

By NIHR Maudsley BRC at 23 Jun 2025

Weight loss behaviours missing in tools to diagnose eating disorders

Researchers at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London have identified a range of weight loss behaviours which are not included in current assessment criteria for eating disorders. These gaps may lead to missed or incorrect eating disorder diagnoses and treatment plans.

By NIHR Maudsley BRC at 18 Jun 2025

Who benefits from antidepressants? Using medication switching as a measure of non-response

Switching from one selective serotonin reuptake inhibitor (SSRI) to another antidepressant could be used to measure antidepressant non-response, according to new research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London.

 

By NIHR Maudsley BRC at 28 May 2025

Ubrogepant found to be effective at reducing non-headache related symptoms of migraine

New research from King’s College London has found that ubrogepant – a drug used to manage migraine attacks – can effectively reduce the non-headache related symptoms when taken one to six hours prior to a migraine headache beginning.

 

By NIHR Maudsley BRC at 14 May 2025

New research finds Motor Neuron Disease drug safe and effective at low doses

New research from the MIROCALS (Modifying Immune Responses and Outcomes in ALS) clinical trial has found that low-dose interleukin-2 (IL2LD) is both safe and effective for use on people with Motor Neurone Disease (MND), also known as amyotrophic lateral sclerosis (ALS) compared to placebo.

 

By NIHR Maudsley BRC at 12 May 2025